Simon de Denus

Dr. Simon de Denus


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2019 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
SPSylvie Perreault
Sylvie Perreault
SDSimon de Denus
Simon de Denus
BWBrian White‐Guay
Brian White‐Guay
RCRobert Côté
Robert Côté
MSMireille E. Schnitzer
Mireille E. Schnitzer
Jean-Claude TardifJean-Claude Tardif
Jean-Claude Tardif

17 January 2013 in Pharmacogenomics
Verified
Journal Article
Closed access
SDSimon de Denus
Simon de Denus
NLNathalie Letarte
Nathalie Letarte
THThierry Hurlimann
Thierry Hurlimann
JLJean-Philippe Lambert
Jean-Philippe Lambert
ALAnnie Lavoie
Annie Lavoie
BVBarbara Vadnais
Barbara Vadnais
Given their expertise in pharmacotherapy, pharmacists are well positioned to play a leading role in the implementation of pharmacogenomics in clinical practice. However, little is known about the opinions of pharmacists towards pharmacogenomics or their willingness to integrate this new field in their practice. We conducted a survey of 284 pharmacists practicing in the province of Québec (Canada) to describe the opinions, expectations and concerns of pharmacists toward pharmacogenomics. Pharmacists were very hopeful regarding the potential role of pharmacogenomics. Moreover, more than 95% of responders would be willing to recommend pharmacogenomic testing. Nevertheless, only 7.7% of pharmacists currently felt comfortable advising patients based on pharmacogenomic test results. Accordingly, the majority of responders (96.6%) indicated that they would like to undertake continuing education related to pharmacogenomics. Pharmacists are extremely hopeful towards pharmacogenomic testing. Furthermore, a vast majority is willing to integrate these tests as part of their clinical practice. Proper education will be required if the integration of pharmacogenomics in patient care is to be optimal.

2 October 2012 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
LVLucie Verret
Lucie Verret
JCJustine Couturier
Justine Couturier
ARAndréanne Rozon
Andréanne Rozon
SSSarah Saudrais‐Janecek
Sarah Saudrais‐Janecek
ASAmélie St‐Onge
Amélie St‐Onge
SDSimon de Denus
Simon de Denus

18 August 2016 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
FRFrançois Rinaldi
François Rinaldi
SDSimon de Denus
Simon de Denus
ANAngela Nguyen
Angela Nguyen
SNStanley Nattel
Stanley Nattel
JBJean-François Bussières
Jean-François Bussières

1 April 2020 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
SDSimon de Denus
Simon de Denus
GLGrégoire Leclair
Grégoire Leclair
MDMarie-Pierre Dubé
Marie-Pierre Dubé
ISIsabelle St-Jean
Isabelle St-Jean
YZYassamin Feroz Zada
Yassamin Feroz Zada
Andreas KalogeropoulosAndreas Kalogeropoulos
Andreas Kalogeropoulos

10 October 2013 in Current Heart Failure Reports
Verified
Journal Article
Closed access
PDF file
EOEileen O’meara
Eileen O’meara
SDSimon de Denus
Simon de Denus
JRJean-Lucien Rouleau
Jean-Lucien Rouleau
ADAkshay Desai
Akshay Desai